After an unprecedented multi-year bull run, biotech is facing headwinds once again. Drug companies have become a target in an election year, putting pricing strategies under a microscope. Valuations have tumbled, drying up a fertile ground for IPOs. Yet biotech innovation continues apace, particularly in Boston. New ways of harnessing the immune system to battle cancer are being unlocked. Investments in neuroscience, long a drug development minefield, have picked up. Biotechs are taking aim at a dangerous liver disease that looms as a potential nationwide epidemic. And local venture firms are armed with new funds to spend on startups.
What ideas are innovators focusing on? What hurdles do they have to cross? And how, in a more challenging environment, can those ideas best move forward?
Join Xconomy as we bring together a group of Boston biotech’s top entrepreneurs, investors, and leaders to explore these, and other topics on the local life sciences horizon.
Phillip A. Sharp, Nobel Laureate; Institute Professor, MIT
Bruce Booth, Partner, Atlas Venture
Don Nicholson, CEO, Nimbus Therapeutics
Deborah Dunsire, CEO, Forum Pharmaceuticals
Gregory Verdine, Founder & CSO, Warp Drive Bio; Professor, Harvard University
Al Sandrock, EVP & Chief Medical Officer, Biogen
Peter Hecht, CEO, Ironwood Pharmaceuticals
Jens Eckstein, President, SR One
Peter Kolchinsky, Founder & Managing Director, RA Capital
Nir Hacohen, Co-founder, Neon Therapeutics; Director, MGH Center for Immunotherapy
Cary Pfeffer, Interim CEO, Neon Therapeutics; Partner, Third Rock Ventures
Daphne Zohar, CEO, Puretech Health
Robert Urban, Head, Johnson & Johnson Innovation, Boston
Tillman U. Gerngross, Professor of Bioengineering, Dartmouth College
Samantha Singer, COO, Broad Institute
Registration & Networking: 12:30 - 1:30 pm
Program: 1:30 - 5:30 pm
Networking Reception: 5:30 - 6:30 pm
View the full agenda.
Tickets are transferable but not refundable.
To inquire about press registration, email email@example.com.
*Speakers and program schedule are subject to change.
VENTURE CAPITAL MEMBERS
LIFE SCIENCE MEMBERS
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, Indiana, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.